5-Nitro-5'-hydroxy-indirubin-3'-oxime (AGM130), an indirubin-3'-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo.
- DOI
- 10.1016/j.ejps.2015.08.015
- Published
- 2015-09-02
- Container
- Eur J Pharm Sci
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejps.2015.08.015,
title = {5-Nitro-5'-hydroxy-indirubin-3'-oxime (AGM130), an indirubin-3'-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo.},
author = {Ahn MY and Kim TH and Kwon SM and Yoon HE and Kim HS and Kim JI and Kim YC and Kang KW and Ahn SG and Yoon JH.},
year = {2015},
journal = {Eur J Pharm Sci},
doi = {10.1016/j.ejps.2015.08.015},
url = {https://doi.org/10.1016/j.ejps.2015.08.015}
}RIS
TY - JOUR TI - 5-Nitro-5'-hydroxy-indirubin-3'-oxime (AGM130), an indirubin-3'-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo. AU - Ahn MY AU - Kim TH AU - Kwon SM AU - Yoon HE AU - Kim HS AU - Kim JI AU - Kim YC AU - Kang KW AU - Ahn SG AU - Yoon JH. PY - 2015 JO - Eur J Pharm Sci DO - 10.1016/j.ejps.2015.08.015 UR - https://doi.org/10.1016/j.ejps.2015.08.015 ER -
APA
MY, A., TH, K., SM, K., HE, Y., HS, K., JI, K., YC, K., KW, K., SG, A., & JH., Y. (2015). 5-Nitro-5'-hydroxy-indirubin-3'-oxime (AGM130), an indirubin-3'-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo.. Eur J Pharm Sci. https://doi.org/10.1016/j.ejps.2015.08.015
Source records
- europe-pmc · retrieved 2026-09-27T01:04:37.660Z